跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
QUVIVIQ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
QUVIVIQ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
QUVIVIQ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Idorsia Pharmaceuticals Deutschland Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 28, 2022
Approval ID
d6ce86511d6cfb43
Company
Idorsia Pharmaceuticals Deutschland Gmbh
Type
Standard
Approval Details
Approval Id
d6ce86511d6cfb43
Drug Cima Aemps Name
QUVIVIQ 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1221638002
Holder Company Name
Idorsia Pharmaceuticals Deutschland Gmbh
Marketing Company Name
Idorsia Pharmaceuticals Spain S.L.
Holder Company Detail Path
/organization/idorsia-pharmaceuticals-deutschland-gmbh
Authorization Date
2022-12-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
25 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Idorsia Pharmaceuticals Deutschland Gmbh
Company Detail Path
/organization/idorsia-pharmaceuticals-deutschland-gmbh
Company Information
Pharmaceutical Company Name
Idorsia Pharmaceuticals Deutschland GmbH
Country Name
Germany
City Name
lörrach,baden-württemberg,country_de
Address
Marie-Curie-Str. 8
Active Ingredients
DARIDOREXANT HIDROCLORURO
27,02 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 28, 2022
Approval ID
d6ce86511d6cfb43
Type
Standard
Back to CIMA-AEMPS Approvals